Geode Capital Management’s ABVC BioPharma ABVC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $246K | Buy |
110,499
+6,017
| +6% | +$13.4K | ﹤0.01% | 3805 |
|
|
2025
Q1 | $111K | Buy |
104,482
+25,197
| +32% | +$26.7K | ﹤0.01% | 4007 |
|
|
2024
Q4 | $46.8K | Buy |
79,285
+7,678
| +11% | +$4.53K | ﹤0.01% | 4253 |
|
|
2024
Q3 | $48.9K | Buy |
71,607
+16,382
| +30% | +$11.2K | ﹤0.01% | 4270 |
|
|
2024
Q2 | $42.7K | Buy |
55,225
+33,225
| +151% | +$25.7K | ﹤0.01% | 4311 |
|
|
2024
Q1 | $28.8K | Buy |
22,000
+2,520
| +13% | +$3.3K | ﹤0.01% | 4426 |
|
|
2023
Q4 | $22.6K | Hold |
19,480
| – | – | ﹤0.01% | 4496 |
|
|
2023
Q3 | $20.3K | Sell |
19,480
-119,802
| -86% | -$125K | ﹤0.01% | 4623 |
|
|
2023
Q2 | $71K | Hold |
139,282
| – | – | ﹤0.01% | 4434 |
|
|
2023
Q1 | $87.8K | Hold |
139,282
| – | – | ﹤0.01% | 4386 |
|
|
2022
Q4 | $87K | Sell |
139,282
-371
| -0.3% | -$232 | ﹤0.01% | 4442 |
|
|
2022
Q3 | $122K | Buy |
139,653
+89,738
| +180% | +$78.4K | ﹤0.01% | 4473 |
|
|
2022
Q2 | $52K | Hold |
49,915
| – | – | ﹤0.01% | 4765 |
|
|
2022
Q1 | $136K | Hold |
49,915
| – | – | ﹤0.01% | 4539 |
|
|
2021
Q4 | $169K | Hold |
49,915
| – | – | ﹤0.01% | 4553 |
|
|
2021
Q3 | $115K | Buy |
+49,915
| New | +$115K | ﹤0.01% | 4637 |
|